Dr. Jeffrey S. Dome
Claim this profileChildren's National Medical Center
Expert in Tumors
Expert in Cancer
64 reported clinical trials
112 drugs studied
About Jeffrey S. Dome
Education:
- Holds both an MD (Doctor of Medicine) and a PhD (Doctor of Philosophy).
Experience:
- Currently the Senior Vice President of the Center for Cancer and Blood Disorders at Children's National Hospital.
- Elected as the Continental President of North America for the International Society of Paediatric Oncology (SIOP) in March 2021.
- Chaired the 49th annual SIOP congress in Washington, D.C., in 2017.
- Has been an active member of SIOP since attending his first meeting in 2005, including serving on the SIOP Board of Directors.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Cancer
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Children's National Medical Center
Golisano Children's Hospital Of Southwest Florida
Clinical Trials Jeffrey S. Dome is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Jeffrey S. Dome
Clinical Trial Related7 years of experience running clinical trials · Led 64 trials as a Principal Investigator · 28 Active Clinical TrialsTreatments Jeffrey S. Dome has experience with
- Cyclophosphamide
- Radiation Therapy
- Nivolumab
- Etoposide
- Vincristine Sulfate
- Laboratory Biomarker Analysis
Breakdown of trials Jeffrey S. Dome has run
Tumors
Cancer
Brain Tumor
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey S. Dome specialize in?
Jeffrey S. Dome focuses on Tumors and Cancer. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Jeffrey S. Dome currently recruiting for clinical trials?
Yes, Jeffrey S. Dome is currently recruiting for 22 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey S. Dome has studied deeply?
Yes, Jeffrey S. Dome has studied treatments such as Cyclophosphamide, Radiation Therapy, Nivolumab.
What is the best way to schedule an appointment with Jeffrey S. Dome?
Apply for one of the trials that Jeffrey S. Dome is conducting.
What is the office address of Jeffrey S. Dome?
The office of Jeffrey S. Dome is located at: Children's National Medical Center, Washington, District of Columbia 20010 United States. This is the address for their practice at the Children's National Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.